Cargando…

A recellularized human colon model identifies cancer driver genes

Refined cancer models are needed to bridge the gap between cell-line, animal and clinical research. Here we describe the engineering of an organotypic colon cancer model by recellularization of a native human matrix that contains cell-populated mucosa and an intact muscularis mucosa layer. This ex v...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Huanhuan Joyce, Wei, Zhubo, Sun, Jian, Bhattacharya, Asmita, Savage, David J, Serda, Rita, Mackeyev, Yuri, Curley, Steven A., Bu, Pengcheng, Wang, Lihua, Chen, Shuibing, Cohen-Gould, Leona, Huang, Emina, Shen, Xiling, Lipkin, Steven M., Copeland, Neal G., Jenkins, Nancy A., Shuler, Michael L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980997/
https://www.ncbi.nlm.nih.gov/pubmed/27398792
http://dx.doi.org/10.1038/nbt.3586
Descripción
Sumario:Refined cancer models are needed to bridge the gap between cell-line, animal and clinical research. Here we describe the engineering of an organotypic colon cancer model by recellularization of a native human matrix that contains cell-populated mucosa and an intact muscularis mucosa layer. This ex vivo system recapitulates the pathophysiological progression from APC-mutant neoplasia to submucosal invasive tumor. We used it to perform a Sleeping Beauty transposon mutagenesis screen to identify genes that cooperate with mutant APC in driving invasive neoplasia. 38 candidate invasion driver genes were identified, 17 of which have been previously implicated in colorectal cancer progression, including TCF7L2, TWIST2, MSH2, DCC and EPHB1/2. Six invasion driver genes that to our knowledge have not been previously described were validated in vitro using cell proliferation, migration and invasion assays, and ex vivo using recellularized human colon. These results demonstrate the utility of our organoid model for studying cancer biology.